Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly high » significantly higher (Expand Search), significantly change (Expand Search), significantly less (Expand Search)
high decrease » slight decrease (Expand Search), high degree (Expand Search), high disease (Expand Search)
Showing 3,201 - 3,220 results of 21,342 for search '(( significantly high decrease ) OR ( significant decrease decrease ))', query time: 0.65s Refine Results
  1. 3201
    ZLN005 increases PGC-1α and TFAM expression.

    ZLN005 increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 3202
    ZLN005 and metformin toxicity in MAC.

    ZLN005 and metformin toxicity in MAC. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3203
    Full Western blot images from manuscript.

    Full Western blot images from manuscript. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 3204
    Metformin rescues PGC-1α expression in presence of inhibitor.

    Metformin rescues PGC-1α expression in presence of inhibitor. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 3205
    Metformin increases PGC-1α and TFAM expression.

    Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 3206
    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α.

    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 3207
    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.

    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 3208
    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB.

    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 3209
    NTM infection induces mitochondrial damage and reduces mitochondria number.

    NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 3210
    The hourly temperatures in the phytotron.

    The hourly temperatures in the phytotron. by Lifeng Guo (17320116)

    Published 2025
    “…After 10 days of exposure to LTS, the pollen viability decreased most significantly at the heading stage by 44.67%, followed by the booting and the tillering stages. …”
    Save to List
    Saved in:
  11. 3211
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 3212
    Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 3213
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 3214
    Average proportion of first choice female applicants stratified by specialty category.

    Average proportion of first choice female applicants stratified by specialty category. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 3215
    Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease.

    Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 3216
    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 3217
    Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023.

    Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 3218
    Flowchart of patient selection in this study.

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 3219
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 3220
    Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023.

    Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: